Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 36, Issue 2, Pages 208-222Publisher
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-013-0023-8
Keywords
Adipose tissue macrophage (ATM); Insulin resistance; Obesity; Inflammation
Categories
Funding
- American Diabetes Association [RA 110BS97]
- Boston Obesity Nutrition Research Center (NIDDK) [DK046200]
- NIH/NIDDK [DK80380]
Ask authors/readers for more resources
It has been increasingly accepted that chronic subacute inflammation plays an important role in the development of insulin resistance and type 2 Diabetes in animals and humans. Particularly supporting this is that suppression of systemic inflammation in type 2 Diabetes improves glycemic control; this also points to a new potential therapeutic target for the treatment of type 2 Diabetes. Recent studies strongly suggest that obesity-induced inflammation is mainly mediated by tissue resident immune cells, with particular attention being focused on adipose tissue macrophages (ATMs). This review delineates the current progress made in understanding obesity-induced inflammation and the roles ATMs play in this process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available